Top news of the week: 06.05.2021.
Companies And Industries
BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says
BioNTech and U.S. partner Pfizer will be able to produce nearly 3 billion doses in 2021, higher than a previously estimated 2.5 billion doses, BioNTech CEO Ugur Sahin told the Financial ...
Researchers wirelessly record human brain activity during normal life activities
NIH BRAIN Initiative-funded study opens the door to correlating deep brain activity and behavior.
Breaking Barriers in Vaccine Development: A Conversation with Dr. Albert Bourla, Chairman and Chief Executive Officer of Pfizer
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
FDA CRL Hurdle for LEO Pharma on Tralokinumab
The U.S. FDA has released a Complete Response Letter (CRL) following its review of LEO Pharma’s tralokinumab. Further data on a device component is the issue brought to light by the ...
Money on the Move: April 29 – May 4
April showers bring May dollars. Here's whose cash gardens are really blooming this week in the life sciences world.
Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene
There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look.
New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy
UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled
Cara's stock tanks as atopic dermatitis phase 2 misses endpoint
A phase 2 trial of Cara Therapeutics’ anti-itch treatment has missed its primary endpoint, sending the biotech’s stock price down 45%. Yet, Cara is forging ahead in atopic dermatitis on the ...